![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Sakurako Takeda, Tatsuya Mimura & Masao Matsubara. (2014) Effect of dorzolamide/timolol combination on the visual field in glaucoma. Clinical Ophthalmology 8, pages 1579-1590.
Read now
Read now
L. Jay Katz, Steven H. Rauchman, Andrew J. Cottingham$suffix/text()$suffix/text(), Steven T. Simmons, Julia M. Williams, Rhett M. Schiffman & David A. Hollander. (2012) Fixed-combination brimonidine–timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Current Medical Research and Opinion 28:5, pages 781-788.
Read now
Read now
Jin-Wei Cheng, Shi-Wei Cheng, Dan-Yang Yu, Rui-Li Wei & Guo-Cai Lu. (2012) Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy. Current Medical Research and Opinion 28:4, pages 543-550.
Read now
Read now
Katrin Lorenz, Klaus Rosbach, Andreas Matt & Norbert Pfeiffer. (2011) Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension. Clinical Ophthalmology 5, pages 1745-1750.
Read now
Read now
Robert D Fechtner, Paul Harasymowycz, Donald R Nixon, Steven D Vold, Fiaz Zaman, Julia M Williams & David A Hollander. (2011) Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost. Clinical Ophthalmology 5, pages 945-953.
Read now
Read now
Nurşen Yüksel, Mustafa Gök, Özgül Altıntaş & Yusuf Çağlar. (2011) Diurnal Intraocular Pressure Efficacy of the Timolol-Brimonidine Fixed Combination and the Timolol-Dorzolamide Fixed Combination as a First Choice Therapy in Patients with Pseudoexfoliation Glaucoma. Current Eye Research 36:9, pages 804-808.
Read now
Read now
Anton Hommer. (2011) Role of fixed combinations in the management of open-angle glaucoma. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 91-99.
Read now
Read now
Eve J Higginbotham. (2010) Considerations in glaucoma therapy: fixed combinations versus their component medications. Clinical Ophthalmology 4, pages 1-9.
Read now
Read now
Nicholas P Bell, José L Ramos & Robert M Feldman. (2010) Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. Clinical Ophthalmology 4, pages 1331-1346.
Read now
Read now
Julián García-Feijoó, Federico Sáenz-Francés, José María Martínez-de-la-Casa, Carmen Méndez-Hernández, Ana Fernández-Vidal, Cristina Calvo-González & Julián García-Sánchez. (2010) Comparison of ocular hypotensive actions of fixed combinations of brimonidine/timolol and dorzolamide/timolol. Current Medical Research and Opinion 26:7, pages 1599-1606.
Read now
Read now
Mamun Q Rahman, Kanna Ramaesh & Donald MI Montgomery. (2010) Brimonidine for glaucoma. Expert Opinion on Drug Safety 9:3, pages 483-491.
Read now
Read now
M Reza Razeghinejad, Andrea K Sawchyn & L Jay Katz. (2010) Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma. Expert Opinion on Pharmacotherapy 11:6, pages 959-968.
Read now
Read now
Articles from other publishers (13)
Masaru Inatani, Yusuke Orii, Kentaro Iwasaki, Shogo Arimura, Hiromi Sunagawa, Minako Shiokawa, Kenji Inoue, Takuto Sakono, Takato Sakono, Rika Kuwamura, Akiko Yoshida, Junko Oi, Yasuaki Kuwayama, Kiyoshi Kano, Noriaki Kido, Akiko Matsuyama, Mineo Ozaki, Hideki Abe, Chizuru Inoue, Satoko Nakagawa, Kunihiro Musashi, Akiyasu Kanamori, Jinhee Lee, Shinichiro Otani, Ryota Aoki, Hirotaka Tanabe, Shunsuke Nakakura, Katsuyoshi Suzuki, Takeshi Sagara, Yoshiaki Saito, Motoyasu Sameshima, Mai Urahashi, Fumika Watanabe-Kitamura, Toshihiro Inoue, Fumie Kagaya, Yusuke Murai, Sotaro Mori, Kaori Ueda, Takuji Kurimoto, Yuko Yamada-Nakanishi, Makoto Nakamura, Takehiro Yamashita, Sosuke Ishiyama, Shinichi Manabe, Keiko Takaki, Ken Hayashi, Akiko Ishida, Aika Tsutsui, Kaoru Manabe & Masaki Tanito. (2023) Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study. Advances in Therapy 40:9, pages 4074-4092.
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
S. Yu. Petrov, V. S. Zinina & A. V. Volzhanin. (2018) The role of fixed dose combinations in the treatment of primary open-angle glaucoma. Vestnik oftal'mologii 134:4, pages 100.
Crossref
Crossref
Dmitry V. Lipatov, Timofey A. Chistykov, Anatoly G. Kuzmin & Anna A. Tolkacheva. (2017) Evaluation of effectiveness of contact transscleral diode laser cyclocoagulation drainage after neovascular glaucoma surgery. Diabetes mellitus 20:4, pages 257-262.
Crossref
Crossref
Anjum Cheema, Robert T. Chang, Anurag Shrivastava & Kuldev Singh. (2016) Update on the Medical Treatment of Primary Open-Angle Glaucoma. Asia-Pacific Journal of Ophthalmology 5:1, pages 51-58.
Crossref
Crossref
Joon Mo Kim, Tae-Woo Kim, Chan Yun Kim, Hwang Ki Kim & Ki Ho Park. (2015) Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5 % timolol in normal-tension glaucoma patients. Japanese Journal of Ophthalmology 60:1, pages 20-26.
Crossref
Crossref
Göktuğ Seymenoğlu, Esin F. Baser, Bilge Öztürk & Ceren Gülhan. (2015) Comparison of Dorzolamide/Timolol Versus Brimonidine/Timolol Fixed Combination Therapy in the Management of Steroid-Induced Ocular Hypertension. Journal of Glaucoma 24:2, pages 111-116.
Crossref
Crossref
Donald R. Nixon. (2013) A Randomized, Prospective Study of Bimatoprost 0.01% or Travoprost/Timolol in Patients Previously Treated with Latanoprost and Timolol to Reduce Intraocular Pressure. Journal of Ocular Pharmacology and Therapeutics 29:10, pages 876-881.
Crossref
Crossref
T Realini, Q H Nguyen, G Katz & H DuBiner. (2013) Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies. Eye 27:7, pages 841-847.
Crossref
Crossref
Patrick BudengeriJin-Wei ChengJi-Ping CaiRui-Li Wei. (2013) Efficacy and Tolerability of Fixed Combination of Brimonidine 0.2%/Timolol 0.5% Compared with Fixed Combination of Dorzolamide 2%/Timolol 0.5% in the Treatment of Patients with Elevated Intraocular Pressure: A Meta-Analysis of Randomized Controlled Trials. Journal of Ocular Pharmacology and Therapeutics 29:5, pages 474-479.
Crossref
Crossref
A G P Konstas, L Quaranta, D B Yan, D G Mikropoulos, I Riva, N K Gill, K Barton & A-B Haidich. (2011) Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma. Eye 26:1, pages 80-87.
Crossref
Crossref
Gokhan Gulkilik, Ersin Oba & Mahmut Odabası. (2011) Comparison of fixed combinations of dorzolamide/timolol and brimonidine/timolol in patients with primary open-angle glaucoma. International Ophthalmology 31:6, pages 447-451.
Crossref
Crossref
Stella Arthur & Louis B. Cantor. (2011) Update on the role of alpha-agonists in glaucoma management. Experimental Eye Research 93:3, pages 271-283.
Crossref
Crossref